News

A guide to getting the most out of your stay during the XXXII Congress of the ESCRS.

Vasodilators and oral beta-blockers are associated with an increase in the hazard of incidence of early age-related macular degeneration (AMD) and exudative AMD, respectively, according to research recently published online.

Forty potential new treatments for inherited retinal diseases are under development, according to a review by the National Institute for Health Research (NIHR) Horizon Scanning Centre (HSC), working with charitable organization Fight for Sight.

A stable IOL, decreased pseudophacodonesis and improved graft fixation are the benefits of combining Descemet membrane endothelial keratoplasty with glued intrascleral haptic fixation of a posterior-chamber IOL in patients with aphakic or pseudophakic bullous keratopathy, according to recently published research.

Fasting significantly reduces the amount of tears produced by the eye and increases the osmolarity of the tears, according to new research.

When detecting and evaluating the progression of glaucoma, Bruch's membrane opening-minimum rim width (BRO-MRW) may be the best predictor of the threshold of visual sensitivity and total deviation of visual field, according to a new study.

The systemic pharmacokinetics and pharmacodynamics of three anti-vascular endothelial growth factor (VEGF) treatments after they are administered intravitreally differ in ways that "may provide biological plausibility for potential differences in systemic safety risk," according to recently published research.

Removal of a cataract and implantation of an intraocular lens (IOL) improves overall sleep quality and sleep latency, according to a study published online before print.

In 2010, 2.1 million people were blind and 6 million people were visually impaired because of macular diseases other than diabetic maculopathy, according to a meta-analysis conducted by members of the Vision Loss Expert Group of the Global Burden of Disease Study Group.

Diurnal IOP curves have limited value in clinical practice for patients with primary open-angle glaucoma (POAG), according to a newly published study.

When performing corneal collagen crosslinking (CXL), ophthalmologists should monitor the keratoconus index and the index of height asymmetry garnered from the Scheimpflug camera, because changes in values of these indices are independent from initial corneal thickness.

It is relatively safe and effective for infants to undergo primary IOL implantation for the correction of aphakia after having one cataract removed, according to new research out of China.

Attaining a higher level of education and spending more years in school are associated with a greater prevalence and severity of myopia, according to a new study published online.

The addition of diquafosol tetrasodium (DQS) to a regimen of artificial tears and sodium hyaluronate helped relieve the symptoms of persistent dry eye in patients who had undergone laser in situ keratomileusis (LASIK), according to recent research.

The 32nd congress of the European Society of Cataract and Refractive Surgeons (ESCRS) is once again proving delectably inviting to the majority of the ophthalmology community. Not only is this the biggest event on the calendar but this year we will see it joining forces with EURETINA and EuCornea, which will surely ensure that it will be a busy and exciting congress.

In this article, Dr Kov?cs discusses his recent study evaluating whether femtosecond laser-assisted capsulotomy has an effect on the incidence of PCO when compared to the manual technique.

In this article, the authors discuss their research into alkylphosphocholine coated IOLs, which may offer some hope in the prevention of PCO in the future.

To address issues around ourcomes, dosing and safety of anti-VEGFs, an independent scientific symposium (sponsored by Novartis) was held during COPHy. Here, we present some brief highlights of this meeting.

A brief overview of some of the products that will be showcased during the ESCRS Congress

A diffractive trifocal IOL (FineVision, PhysIOL) provides a peak modulation transfer function for intermediate vision.

The AREDS 1 and 2 studies provide important information about the role of ocular nutrition in macular degeneration. However, to benefit patients, the findings must be condensed into clear and concise advice that will help them select appropriate vitamin supplements and follow a healthy lifestyle.

Gonioscopy-assisted transluminal trabeculotomy is a circumferential trabeculotomy performed via a minimally invasive, ab interno approach. Results from follow-up of 6 to 12 months in a series of 85 adult eyes with uncontrolled glaucoma show high IOP lowering, along with a reduced need for medication.

Currently, there is no treatment to promote the healing of endothelial cells, however, the extent of the corneal oedema can be controlled. In this article, Prof. Feinbaum discusses a new treatment option aimed at alleviating complications of visual loss and pain secondary to corneal oedema.

Posterior capsule opacification (PCO) is a frequent and important complication noticed in diabetics undergoing cataract surgery, however, few studies have examined the prevalence of PCO in diabetic versus non-diabetic patients. Therefore, the authors performed a study exploring the long-term effect of diabetes on the incidence of PCO and here they highlight their findings.

The National Aeronautics and Space Administration (NASA) Ocular Health Study has been named as the recipient of Heidelberg Engineering's 2014 Xtreme Research Award.

A single, 1.0 or 2.0 mg intravitreal injection of the designed ankyrin repeat protein (DARPin) MP0112 showed promising efficacy and long-term duration in a trial of patients with age-related macular degeneration (AMD).

When people sleep with their heads elevated 20 degrees, their nocturnal IOP is lower than when they sleep with their heads flat, finds a newly published study.

Optical coherence tomography (OCT) can be used to characterize the angle and topography of the corneoscleral junction, according to newly published research.

Bayer HealthCare has applied to the EMA for marketing authorization of aflibercept solution for injection for the treatment of patients with visual impairment caused by macular oedema secondary to BRVO.

Increased blood pressure contributes to elevated IOP and possibly the development of glaucoma, according to the findings of a recent meta-analysis.